Gene · 10481
HOXB13: homeobox B13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. HOXB13: homeobox B13. Genes, record 10481. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10481
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92826 | Homeobox protein Hox-B13 | 284 | 10 | Ensembl, GeneID, HGNC |
Source UniProt
Patents63
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4805378 A1 | 2026-09-16 | 111 | Q92826 | Espacenet |
| JP 2026523341 A | 2026-07-14 | 570 | Q92826 | Espacenet |
| EP 4771137 A1 | 2026-07-08 | 108 | Q92826 | Espacenet |
| EP 4771157 A1 | 2026-07-08 | 108 | Q92826 | Espacenet |
| US 12649003 B2 | 2026-06-09 | 570 | Q92826 | Espacenet |
| JP 2026510339 A | 2026-04-02 | 108 | Q92826 | Espacenet |
| EP 4713451 A2 | 2026-03-25 | 108 | Q92826 | Espacenet |
| EP 4713452 A2 | 2026-03-25 | 108 | Q92826 | Espacenet |
| US 12558437 B2 | 2026-02-24 | 570 | Q92826 | Espacenet |
| EP 4677082 A2 | 2026-01-14 | 108 | Q92826 | Espacenet |
1 to 10 of 63
See all 63 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,266
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HOXB13 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 35 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 29 | 2025 |
| P01CA163227 | Androgen Receptor Action in Castration Resistant Prostate Cancer | 22 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 20 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 18 | 2025 |
| P50CA186786 | Michigan Prostate SPORE 2025-2030 | 18 | 2025 |
| P50CA092629 | SPORE in Prostate Cancer | 17 | 2025 |
| P50CA180995 | SPORE in Prostate Cancer | 13 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 10 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 8 | 2025 |
1 to 10 of 1,266Source NIH's project files
See all 1,266 nih grantsPapers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breast Cancer Index and Recommendations for Extended Endocrine Therapy. | JAMA Netw Open | 2026 | 42783373 | PubTator, text mining | PubMed |
| Post-translational modifications in prostate cancer: coordinated oncogenic networks and clinical implications. | Biochim Biophys Acta Rev Cancer | 2026 | 42637058 | PubTator, text mining | PubMed |
Correction to "Homeobox B13 activates the hypoxia-inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma". | J Cell Commun Signal | 2026 | 42621181 | PubTator, text mining | PubMed |
| Germline HOXB13 G84E Variant in a Patient with Gastric and Prostate Cancer: A Case Report and Literature Review. | Case Rep Oncol | 2026 | 42578161 | PubTator, text mining | PubMed |
| Unified genetic risk score for prostate cancer enables improved risk stratification for clinical decision-making. | J Med Genet | 2026 | 42527158 | PubTator, text mining | PubMed |
| Revisiting familial aggregation of prostate cancer within the 3D framework of genetics-epigenetics-environment. | Mutat Res Rev Mutat Res | 2026 | 42492399 | PubTator, text mining | PubMed |
| Miniaturized HOXB13 Mimetics Are Sequence-Specific, Methyl-Sensitive DNA Binders. | J Am Chem Soc | 2026 | 42445955 | PubTator, text mining | PubMed |
| HOXB13 Is a Sensitive and Specific Diagnostic Marker for Myxopapillary Ependymoma. | Am J Surg Pathol | 2026 | 42444158 | PubTator, text mining | PubMed |
| Hereditary Cancer Genetic Testing for All? A Retrospective Analysis on Genetic Mutations Found in Individuals Not Meeting NCCN® Guidelines. | Eur J Breast Health | 2026 | 42317085 | PubTator, text mining | PubMed |
| The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study. | BJU Int | 2026 | 42265755 | PubTator, text mining | PubMed |
1 to 10 of 1,917
See all 1,917 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10481
GET https://conductscience.org/api/genes/v1/10481/patents?page=2